Market Capitalization Endring Dato
AbbVie USD 313.64B 40.03B 2024-03
Acadia Pharmaceuticals USD 2.96B 2.18B 2024-03
Acorda Therapeutics USD 16M 2M 2023-06
ALKERMES USD 4.63B 36M 2023-12
Amgen USD 148.35B 5.79B 2024-03
Biogen USD 31.4B 6.09B 2024-03
BioMarin Pharmaceutical USD 15.87B 2.29B 2024-03
Bluebird Bio USD 244M 19M 2024-03
Bristol-Myers Squibb USD 105.66B 1.26B 2024-03
Eli Lilly USD 731.69B 178.32B 2024-03
Gilead Sciences USD 90.93B 10.01B 2024-03
Heron Therapeutics USD 145M 6M 2023-09
Intra Cellular Therapies USD 6.67B 227M 2024-03
Ionis Pharmaceuticals USD 6.19B 1.07B 2024-03
J&J USD 375.41B 1.91B 2024-03
Malin Corporation EUR 88.78M 158.03M 2023-06
Marinus Pharmaceuticals USD 407M 142M 2023-09
Merck USD 314.33B 38.07B 2024-03
Minerva Neurosciences USD 43M 5M 2023-12
Nektar Therapeutics USD 113M 4M 2023-09
Neurocrine Biosciences USD 14.28B 1.33B 2024-03
Otsuka Holdings JPY 2.95T 14.58B 2023-12
Ovoca Bio GBP 7.54M 4.28M 2022-06
Pfizer USD 155.51B 7.05B 2024-03
Regeneron Pharmaceuticals USD 106.74B 11.05B 2024-03
Revance Therapeutics USD 772M 237M 2023-12
Vertex Pharmaceuticals USD 106.53B 1.68B 2024-03



ALKERMES Marketskapitalisme - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2024.